Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina's announcement of agreement to acquire SomaLogic SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) today announced the [...]

New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the [...]

Durham, NC – EpiCypher®, a pioneer in epigenomic research and technology, announces the launch of CUTANA® Fiber-seq, a groundbreaking multiomic genomics platform that captures both genomic and epigenomic information in a single long-read sequencing assay. This first-of-its-kind technology delivers unprecedented resolution of DNA sequence and chromatin features along individual DNA molecules, opening an entirely new dimension [...]

Partnership aimed at improving cell separation and increasing cell viability WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) and Akadeum Life Sciences, a leader in advanced cell separation technologies, announced today the integration of Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit into Charles River’s Cell Therapy Flex Program. Charles River’s Cell Therapy Flex [...]

DÜSSELDORF, Germany – LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration combines LenioBio’s proprietary cell-free protein expression platform, ALiCE®, with AffinityAI’s advanced design engine, Designerbodies™, to significantly accelerate the discovery and optimization de novo proteins. By integrating AI-guided protein design with high-throughput cell-free expression, the partnership [...]

Liebherr USA, Co., refrigerators and freezers is proud to introduce its latest line of high-performance refrigerators and freezers featuring outstanding performance. Purpose-built for research facilities and laboratories, these state-of-the-art appliances are engineered to deliver superior quality, maximum reliability, and advanced safety for the storage of sensitive materials. Liebherr new High-performance laboratory refrigerators and freezers Liebherr [...]

A new Hereditary Cancer Panel will interrogate 258 genes associated with inherited cancer risk Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has launched a comprehensive Hereditary Cancer Panel (HCP), which will allow users to interrogate 258 key genes associated with inherited cancer risk. The HCP provides a simple [...]

Tokyo, Japan – Rigaku Corporation, a global solutions partner in X-ray analytical instruments and a member of the Rigaku Holdings Group (Headquarters: Akishima, Tokyo; President: Jun Kawakami; hereafter “Rigaku”), today announced the launch of the DicifferX WAXS Edition, an advanced X-ray diffraction system for polymer structure analysis that dramatically improves efficiency in laboratory environments. The [...]

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries  The acquisition creates the largest global 'software pure player' in the clinical genomics space, which will maintain UK presence at the renowned Wellcome Sanger Institute MONTPELLIER, France, and CAMBRIDGE, UK: SeqOne, a pioneer in [...]

Europa Biosite is pleased to announce that Bio X Cell has appointed Cambridge Bioscience, a proud member of Europa Biosite, as its exclusive distributor for the United Kingdom and Ireland. This strategic partnership ensures that researchers across the UK and Ireland will have streamlined access to the Bio X Cell portfolio which features best-in-class functional monoclonal [...]